News & Articles

Newly-innovated design reduces heat generation by 40%, enabling smaller radar systems

Partnership to enable HYGEIA’s hospital network to develop and deliver onsite cell and gene therapies to patients

Anaerobes course to return for its sixth year

Immunovia will receive fresh blood samples from the pharmaceutical partner for analysis

Researchers found that using dichloroacetate to treat the cells of women with endometriosis lowered the production of lactate, and stopped abnormal cell growth

Horizon's CRISPR-edited knockout cell models to further expand the knowledge available in the Cell Atlas program

Differences in the raman spectra of silicon samples as a function of temperature uncovers separate phases

Initial twelve-month collaboration successfully identifies hit compounds and progresses into hit-to-lead optimization phase

New approach to ion exchange membrane design uses low-cost plastic membranes with hydrophilic pores

Rigaku is showcasing its XRD, XRF and Raman instrumentation at the 2019 Materials Research Society Fall Meeting & Exhibit in Boston

Abcam's new offering enables proteomic studies by providing

The approach lays the foundation for novel ways to map connections across different brain regions

Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies

Series of free explainer infographics summarize headspace, SPME, high capacity sorptive extraction (HiSorb) and thermal desorption

BINDER named one of the most innovative companies in Germany

Researcher Meritxell Huch awarded the BINDER Innovation Prize

Automation customers throughout the region gain convenient access to hands-on education and ongoing support services

Clinical trial will evaluate the safety and immunogenicity of Entervax™

New ZEISS iCeMS Innovation Core collaborative laboratory opened

Money will help fund the international DUNE experiment

New aerodynamic materials developed are sent to investigate erosion properties in low earth orbit

Abbott is making this new strain accessible to the research community to evaluate its impact on diagnostics, treatment and potential vaccines